|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
WO1999000113A1
(en)
|
1997-06-27 |
1999-01-07 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
DE69403966T3
(de)
|
1993-07-19 |
2008-04-17 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Anti-angiogene mittel und verfahren zu deren verwendung
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
US5874029A
(en)
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
|
WO1997045105A1
(en)
|
1996-05-24 |
1997-12-04 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
|
US5756537A
(en)
|
1996-11-08 |
1998-05-26 |
Parkash S. Gill, M.D., Inc. |
Regime for paclitaxel in Kaposi's sarcoma patients
|
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US6113795A
(en)
|
1998-11-17 |
2000-09-05 |
The University Of Kansas |
Process and apparatus for size selective separation of micro- and nano-particles
|
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
|
IN191203B
(enExample)
|
1999-02-17 |
2003-10-04 |
Amarnath Prof Maitra |
|
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
|
US7217735B1
(en)
|
1999-04-09 |
2007-05-15 |
Au Jessie L-S |
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
HK1048956B
(zh)
|
1999-05-27 |
2006-07-28 |
阿库斯菲尔公司 |
多孔药物基质及其制造方法
|
|
US6892091B1
(en)
|
2000-02-18 |
2005-05-10 |
Biosense, Inc. |
Catheter, method and apparatus for generating an electrical map of a chamber of the heart
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
US20040033267A1
(en)
|
2002-03-20 |
2004-02-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
JP2005507874A
(ja)
*
|
2001-08-29 |
2005-03-24 |
ユーエムディー， インコーポレイテッド |
癌治療のための化学療法剤及び膜流出システム阻害剤の経膣送達
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
WO2003032906A2
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
|
US20080220075A1
(en)
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
KR100533458B1
(ko)
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
|
JP2006514698A
(ja)
|
2002-10-30 |
2006-05-11 |
スフェリックス， インコーポレイテッド |
ナノ粒子生物活性物質
|
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
FR2856301B1
(fr)
|
2003-06-23 |
2007-08-03 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
WO2005039533A1
(en)
|
2003-10-15 |
2005-05-06 |
Medigene Ag |
Method of administering cationic liposomes comprising an active drug
|
|
WO2005044234A2
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
FR2862540B1
(fr)
|
2003-11-21 |
2007-03-30 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
FR2871697B1
(fr)
|
2004-06-17 |
2007-06-29 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
|
|
FR2871695B1
(fr)
|
2004-06-17 |
2008-07-04 |
Galderma Sa |
Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
|
|
US7361683B2
(en)
|
2004-11-24 |
2008-04-22 |
Yung Shin Pharm. Ind., Co., Ltd |
Paclitaxel aqueous injection solution and methods for preparing the same
|
|
US8062658B2
(en)
|
2004-12-14 |
2011-11-22 |
Poly-Med, Inc. |
Multicomponent bioactive intravaginal ring
|
|
KR20080003322A
(ko)
|
2005-02-24 |
2008-01-07 |
엘란 파마 인터내셔널 리미티드 |
도세탁셀 및 이의 유사체의 나노입자 배합물
|
|
GB0506139D0
(en)
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
|
CN101189014A
(zh)
|
2005-04-27 |
2008-05-28 |
莱顿大学医学中心 |
用于治疗hpv诱导的上皮内瘤样病变的方法和手段
|
|
WO2006133271A2
(en)
|
2005-06-06 |
2006-12-14 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
BRPI0619967A2
(pt)
|
2005-12-14 |
2011-10-25 |
Organogenesis Inc |
composições para o cuidado da pele
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
US8343962B2
(en)
|
2006-03-06 |
2013-01-01 |
Nuvo Research Inc. |
Topical formulation
|
|
ES2390183T3
(es)
|
2006-10-11 |
2012-11-07 |
Crititech, Inc. |
Método de precipitación de partículas pequeñas de medicamento en recipiente de uso
|
|
US9018146B2
(en)
|
2006-11-22 |
2015-04-28 |
Baker Hughes Incorporated |
Method of treating a well with viscoelastic surfactant and viscosification activator
|
|
US9675578B2
(en)
|
2006-12-14 |
2017-06-13 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
活效製藥股份有限公司 |
微粉碎化有機化合物粒子之製法
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
ITMI20071267A1
(it)
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
CN101129338A
(zh)
|
2007-08-27 |
2008-02-27 |
四川大学 |
超临界流体新技术微细化抗癌药物紫杉醇
|
|
CN101878024B
(zh)
|
2007-11-28 |
2014-04-09 |
塞拉特药物股份有限公司 |
改良的紫杉烷递送系统
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
US8865194B1
(en)
|
2007-12-20 |
2014-10-21 |
Theraplex Company, LLC |
Reducing tackiness and greasiness of petrolatum-like materials
|
|
US20090175810A1
(en)
|
2008-01-03 |
2009-07-09 |
Gareth Winckle |
Compositions and methods for treating diseases of the nail
|
|
US8952075B2
(en)
|
2008-05-22 |
2015-02-10 |
Poly-Med, Inc. |
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
|
|
CN101283976A
(zh)
*
|
2008-05-30 |
2008-10-15 |
济南基福医药科技有限公司 |
一种含紫杉烷类药物的抗癌缓释凝胶注射剂
|
|
US9540695B2
(en)
|
2008-06-17 |
2017-01-10 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis of ovarian cancer
|
|
MX2010013562A
(es)
|
2008-06-26 |
2011-02-15 |
Anterios Inc |
Aplicacion dermica.
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
AU2010302350B2
(en)
|
2009-10-02 |
2015-06-18 |
Journey Medical Corporation |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
|
GB2474930B
(en)
|
2009-10-02 |
2012-07-04 |
Foamix Ltd |
Topical tetracycline compositions
|
|
CN104587484A
(zh)
|
2009-10-13 |
2015-05-06 |
瑞沙恩医药公司 |
用于抗癌剂递送的聚合物系统
|
|
CN101829061A
(zh)
|
2010-05-14 |
2010-09-15 |
无锡纳生生物科技有限公司 |
一种紫杉醇纳米颗粒组合物及其制备方法
|
|
CN101843582B
(zh)
|
2010-05-18 |
2011-12-21 |
南京工业大学 |
紫杉醇纳米混悬剂及其制备方法
|
|
WO2011151418A2
(en)
|
2010-06-02 |
2011-12-08 |
Abbott Gmbh & Co. Kg |
Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
|
|
US8039494B1
(en)
|
2010-07-08 |
2011-10-18 |
Dow Pharmaceutical Sciences, Inc. |
Compositions and methods for treating diseases of the nail
|
|
EP2598114A1
(en)
*
|
2010-07-28 |
2013-06-05 |
Fondazione Irccs "Istituto Nazionale del Tumori" |
Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system.
|
|
WO2012017349A2
(en)
|
2010-08-02 |
2012-02-09 |
Ranbaxy Laboratories Limited |
An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine
|
|
US8563535B2
(en)
|
2011-03-29 |
2013-10-22 |
Kamal Mehta |
Combination composition comprising benzoyl peroxide and adapalene
|
|
WO2012130314A1
(en)
|
2011-03-31 |
2012-10-04 |
Elara Pharmaceuticals Gmbh |
Composition comprising docetaxel
|
|
JP6076962B2
(ja)
*
|
2011-04-01 |
2017-02-08 |
フロリダ大学 リサーチファウンデーション インコーポレイティッド |
治療薬を局所送達するための感熱性を有する粘膜付着性または皮膚粘着性の浸透促進剤
|
|
AU2012251135A1
(en)
|
2011-05-02 |
2013-11-07 |
Lipidor Ab |
Treatment of psoriasis
|
|
BR112013033466A8
(pt)
|
2011-06-27 |
2018-03-06 |
Cristal Delivery B V |
uso de um sistema de liberação controlada e sistema de liberação controlada
|
|
EP2833905B1
(en)
*
|
2012-04-04 |
2018-05-02 |
Halozyme, Inc. |
Combination therapy with hyaluronidase and a tumor-targeted taxane
|
|
US9018246B2
(en)
|
2012-09-05 |
2015-04-28 |
Lp Pharmaceutical (Xiamen) Co., Ltd. |
Transmucosal administration of taxanes
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
JP2014114249A
(ja)
|
2012-12-11 |
2014-06-26 |
Kanae Technos:Kk |
基剤、及び皮膚外用剤
|
|
CA2900136C
(en)
*
|
2013-03-04 |
2021-05-04 |
Astrazeneca Ab |
Combination treatment
|
|
US8778181B1
(en)
|
2013-03-14 |
2014-07-15 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
|
EP2978420A4
(en)
|
2013-03-28 |
2016-12-21 |
Bbs Nanotechnology Ltd |
STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
WO2014210485A1
(en)
|
2013-06-28 |
2014-12-31 |
Bind Therapeutics, Inc. |
Docetaxel polymeric nanoparticles for cancer treatment
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
WO2015187194A1
(en)
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
|
WO2016071365A1
(en)
|
2014-11-03 |
2016-05-12 |
Spherium Biomed, S.L. |
Topical pharmaceutical compositions of paclitaxel
|
|
CN105280869B
(zh)
|
2015-01-07 |
2018-07-31 |
保定钰鑫电气科技有限公司 |
一种组合式蓄电池端子连接片
|
|
JP6758325B2
(ja)
*
|
2015-06-04 |
2020-09-23 |
クリティテック・インコーポレイテッド |
タキサン粒子およびその使用
|
|
CN114588270B
(zh)
|
2015-09-16 |
2024-08-06 |
Dfb索里亚有限责任公司 |
包含紫杉烷类纳米颗粒的组合物及其用途
|
|
CN114767860A
(zh)
|
2016-04-04 |
2022-07-22 |
克里蒂泰克公司 |
实体肿瘤治疗方法
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|